The UK's First Light Fusion plans to build a 60 MW pilot power plant based on its unique projectile fusion technology to prove the integrated engineering for electricity generation and the production of tritium. It has partnered with Canadian Nuclear Laboratories to design a system for extracting tritium from the reactor.

The commercial production of lutetium-177 has begun using a new isotope production system that was installed in unit 7 of the Bruce plant in Ontario, Canada, during a planned maintenance outage earlier this year.

A new peer review service has been launched by the International Atomic Energy Agency in an effort to support countries faced with limited resources and capacities for the management of disused sealed radioactive sources.

The Cyclotron Radiopharmacy Preclinical Complex and the Multipurpose Irradiation Centre at the Centre for Research and Development in Nuclear Technology in Bolivia, have been put into trial operation.

Jamaica has opened its first public nuclear medicine centre with the support of the International Atomic Energy Agency's Rays of Hope initiative. The centre, at the University Hospital of the West Indies (UHWI) in Kingston, will provide diagnosis and treatment for cancer and other diseases including cardiovascular diseases, diabetes and chronic respiratory diseases.

Bruce Power and Kinectrics-Framatome joint venture Isogen are examining the feasibility of producing the medical radioisotope yttrium-90 using the innovative Isotope Production System installed in unit 7 at Bruce Power's nuclear power plant in Ontario.

Lutetium-177 has been produced using a new isotope production system that was installed in unit 7 of the Bruce plant in Ontario, Canada, during a recent planned maintenance outage. It marks the first time the short-lived medical isotope has been produced in a commercial nuclear power reactor.

Tractebel will lead the PULSAR consortium conducting research on dynamic radioisotope power systems fuelled by plutonium-238 for space applications - to provide spacecraft and astronauts with electricity and heat when the sun does not supply enough power.

Scientists at the UK's National Nuclear Laboratory have developed a process for producing the country's first domestically produced supply of the medical radioisotope lead-212.

A new method to extract molybdenum-99 from low-enriched uranium targets, developed by researchers at the Technical University of Munich, could significantly reduce the radioactive waste produced during the production of the isotope. Mo-99 is the precursor for medical radioisotope technetium-99m, used in more than 85% of all nuclear medicine diagnostic examinations.

Belgium's SCK-CEN nuclear research centre has received all the licences needed for the construction and operation of a facility to support the RECUMO project to manage and recycle radioactive residues from the production of medical radioisotopes.

Necsa - the South African Nuclear Energy Corporation - has released a Request for Information for the Multipurpose Reactor to replace the 56-year-old Safari-1 research reactor located at Pelindaba.